KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $4.61 $7.24 Friday, 26th Apr 2024 AFMD stock ended at $5.03. This is 3.07% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.35% from a day low at $4.88 to a day high of $5.19.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
Apr 12, 2016 $45.90 $45.90 $45.90 $45.90 26 550
Apr 11, 2016 $43.20 $43.20 $43.20 $43.20 18 772
Apr 08, 2016 $42.20 $42.20 $42.20 $42.20 11 850
Apr 07, 2016 $42.50 $42.50 $42.50 $42.50 19 097
Apr 06, 2016 $43.80 $43.80 $43.80 $43.80 19 949
Apr 05, 2016 $40.10 $40.10 $40.10 $40.10 24 060
Apr 04, 2016 $42.10 $42.10 $42.10 $42.10 26 571
Apr 01, 2016 $41.20 $41.20 $41.20 $41.20 38 259
Mar 31, 2016 $37.40 $37.40 $37.40 $37.40 30 604
Mar 30, 2016 $36.70 $36.70 $36.70 $36.70 22 232
Mar 29, 2016 $36.90 $36.90 $36.90 $36.90 15 270
Mar 28, 2016 $35.90 $35.90 $35.90 $35.90 18 760
Mar 24, 2016 $37.20 $37.20 $37.20 $37.20 11 440
Mar 23, 2016 $37.50 $37.50 $37.50 $37.50 32 490
Mar 22, 2016 $39.30 $39.30 $39.30 $39.30 25 980
Mar 21, 2016 $38.70 $38.70 $38.70 $38.70 20 190
Mar 18, 2016 $39.60 $39.60 $39.60 $39.60 37 470
Mar 17, 2016 $38.50 $38.50 $38.50 $38.50 20 040
Mar 16, 2016 $37.00 $37.00 $37.00 $37.00 13 630
Mar 15, 2016 $36.80 $36.80 $36.80 $36.80 25 530
Mar 14, 2016 $40.40 $40.40 $40.40 $40.40 17 830
Mar 11, 2016 $39.80 $39.80 $39.80 $39.80 21 050
Mar 10, 2016 $37.40 $37.40 $37.40 $37.40 17 490
Mar 09, 2016 $39.50 $39.50 $39.50 $39.50 21 080
Mar 08, 2016 $40.70 $40.70 $40.70 $40.70 29 480
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT